Five years after surgery, serum prostate-specific antigen maintained to the lowest level so far.<h4>Conclusion</h4>Metastasectomy might be a beneficial therapeutic option to improve the prognosis for solitary metastasis from prostate cancer. The gene discussed is KLK3; the disease is prostate carcinoma.